US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Natera

203.04

+5.963.02%

Post-market: 202.00-1.0400-0.51%18:42 EST

Volume:1.56M

Turnover:313.07M

Market Cap:28.08B

PE:-88.65

High:203.68

Open:199.73

Low:194.02

Close:197.08

52wk High:256.36

52wk Low:125.38

Shares:138.32M

Float Shares:135.00M

Volume Ratio:1.10

T/O Rate:1.16%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.2905

EPS(LYR):-1.5269

ROE:-29.02%

ROA:-12.89%

PB:22.43

PE(LYR):-132.98

Loading ...

Overview Company News Filings

Natera Launches EDEN Study to Assess Early Risk of Preeclampsia in Pregnancy

Natera Inc. Chief Legal Officer Daniel Rabinowitz Reports Disposal of Common Shares

Natera on Track for Longest Losing Streak Since September 2023 -- Data Talk

Exploring US High Growth Tech Stocks This February 2026

Simply Wall St.

BRIEF-Natera Submits Signatera™ CDx PMA To FDA

Natera Submits Signatera CDx Premarket Approval Application to FDA

Natera Submits Signatera™ Cdx Pma to FDA

THOMSON REUTERS

Natera Inc - Submission Supported by Phase 3 Imvigor011 Trial Data

THOMSON REUTERS

The Druckenmiller Connection: Meet the Man Behind Bessent and Warsh -- Barrons.com

Natera Completes Enrollment in ACES-EMB Trial Evaluating Prospera Heart Test for Transplant Rejection Monitoring

Natera Announces Completion of Enrollment in Randomized Aces-Emb Trial in Heart Transplantation

THOMSON REUTERS

Natera Inc. Co-Founder and Director Jonathan Sheena Reports Disposal of Common Shares

Natera Study Shows Prospera Test Reduces Need for Routine Lung Transplant Biopsies

Analysts’ Top Healthcare Picks: Natera (NTRA), Corcept Therapeutics (CORT)

Natera announces publication of validation study for Latitude tissue-free assay

Natera Launches Latitude Tissue-Free MRD Test With High Sensitivity in Colorectal Cancer Study

Natera Showcases Fetal Focus Single Gene NIPT Clinical Trial Results at SMFM Meeting

Natera Targets Endometrial Cancer With New Signatera Trial, Expanding Its MRD Opportunity

Natera Inc. unveils investor presentation highlighting advances in cell-free DNA technology and record growth across core products

Natera’s SCORE Study Builds Real-World Evidence for Cancer MRD Testing

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NTRA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NTRA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NTRA\",,,,,undefined,":{"symbol":"NTRA","market":"US","secType":"STK","nameCN":"Natera","latestPrice":203.04,"timestamp":1770411600000,"preClose":197.08,"halted":0,"volume":1563978,"hourTrading":{"tag":"盘后","latestPrice":202,"preClose":203.04,"latestTime":"18:42 EST","volume":45626,"amount":9263881.73,"timestamp":1770421377383,"change":-1.04,"changeRate":-0.005122,"amplitude":0.005122},"delay":0,"changeRate":0.030241526283742538,"floatShares":135000000,"shares":138321138,"eps":-2.290471,"marketStatus":"Market Closed","change":5.96,"latestTime":"02-06 16:00:00 EST","open":199.73,"high":203.68,"low":194.02,"amount":313069108.47264,"amplitude":0.049016,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.290471,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1435809600000,"exchange":"NASDAQ","adjPreClose":197.08,"preHourTrading":{"tag":"盘前","latestPrice":199.58,"preClose":197.08,"latestTime":"09:25 EST","volume":44889,"amount":8971903.38096,"timestamp":1770387900068,"change":2.5,"changeRate":0.012685,"amplitude":0.047544},"postHourTrading":{"tag":"盘后","latestPrice":202,"preClose":203.04,"latestTime":"18:42 EST","volume":45626,"amount":9263881.73,"timestamp":1770421377383,"change":-1.04,"changeRate":-0.005122,"amplitude":0.005122},"volumeRatio":1.103083326667689,"impliedVol":0.5644,"impliedVolPercentile":0.6733},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NTRA\",,,,,undefined,":{"symbol":"NTRA","floatShares":135000000,"roa":"-12.89%","roe":"-29.02%","lyrEps":-1.526852,"volumeRatio":1.103083326667689,"shares":138321138,"dividePrice":0,"high":203.68,"amplitude":0.049016,"preClose":197.08,"low":194.02,"week52Low":125.38,"pbRate":"22.43","psRate":"13.27","week52High":256.36,"institutionHeld":0,"latestPrice":203.04,"eps":-2.290471,"divideRate":0,"volume":1563978,"delay":0,"ttmEps":-2.290471,"open":199.73,"prevYearClose":229.09,"prevWeekClose":231.14,"prevMonthClose":231.14,"prevQuarterClose":229.09,"fiveDayClose":231.14,"twentyDayClose":239.56,"sixtyDayClose":206.63},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NTRA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-01-11","symbol":"NTRA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1768107600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-11-06","symbol":"NTRA","fiscalQuarterEnding":"2025/09","expectedEps":-0.39,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-0.64},{"market":"US","date":"2025-08-07","symbol":"NTRA","fiscalQuarterEnding":"2025/06","expectedEps":-0.6,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-0.74},{"market":"US","date":"2025-05-08","symbol":"NTRA","fiscalQuarterEnding":"2025/03","expectedEps":-0.59,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":-0.5},{"market":"US","date":"2025-02-27","symbol":"NTRA","fiscalQuarterEnding":"2024/12","expectedEps":-0.42,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"post","actualEps":-0.41}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NTRA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NTRA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3636,"buy":0.5455,"hold":0.0909,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5455,"analysts":22,"updateTime":1770094800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NTRA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NTRA","date":"2026-02-06","current":-88.645523,"percent":0.237398,"low":-123.671425,"twenty":-95.368174,"median":-26.863278,"eighty":-9.465138,"high":-4.957945,"avg":-41.839034,"sd":37.697014,"marketCap":27260329877},"quantilePoints":[{"date":"2021-02-12","current":-56.317305,"twenty":-30.807677,"median":-13.453601,"eighty":-7.516359,"marketCap":10616600390},{"date":"2021-02-19","current":-54.166234,"twenty":-30.807677,"median":-13.453601,"eighty":-7.516359,"marketCap":10211093380},{"date":"2021-02-26","current":-43.746515,"twenty":-30.807677,"median":-13.453601,"eighty":-7.516359,"marketCap":10050455529},{"date":"2021-03-05","current":-38.810006,"twenty":-30.826405,"median":-13.453601,"eighty":-7.510563,"marketCap":8916327117},{"date":"2021-03-12","current":-39.20568,"twenty":-30.826405,"median":-13.453601,"eighty":-7.510563,"marketCap":9007230539},{"date":"2021-03-19","current":-38.93436,"twenty":-30.826405,"median":-13.453601,"eighty":-7.510563,"marketCap":8944896764},{"date":"2021-03-26","current":-35.286619,"twenty":-30.901317,"median":-13.453601,"eighty":-7.516359,"marketCap":8106853784},{"date":"2021-04-01","current":-38.783627,"twenty":-30.901317,"median":-13.453601,"eighty":-7.516359,"marketCap":8910266888},{"date":"2021-04-09","current":-39.559903,"twenty":-30.826405,"median":-13.453601,"eighty":-7.510563,"marketCap":9088610746},{"date":"2021-04-16","current":-40.792361,"twenty":-30.826405,"median":-13.453601,"eighty":-7.510563,"marketCap":9371759413},{"date":"2021-04-23","current":-42.638411,"twenty":-30.826405,"median":-13.453601,"eighty":-7.510563,"marketCap":9795876436},{"date":"2021-04-30","current":-41.963306,"twenty":-30.901317,"median":-13.453601,"eighty":-7.516359,"marketCap":9640775789},{"date":"2021-05-07","current":-34.555683,"twenty":-30.901317,"median":-13.453601,"eighty":-7.516359,"marketCap":8923106695},{"date":"2021-05-14","current":-31.623727,"twenty":-30.707794,"median":-13.453601,"eighty":-7.516359,"marketCap":8166005233},{"date":"2021-05-21","current":-29.200791,"twenty":-30.245835,"median":-13.453601,"eighty":-7.516359,"marketCap":7540344998},{"date":"2021-05-28","current":-31.946106,"twenty":-30.220864,"median":-13.453601,"eighty":-7.516359,"marketCap":8249251343},{"date":"2021-06-04","current":-33.089705,"twenty":-30.220864,"median":-13.453601,"eighty":-7.516359,"marketCap":8544555964},{"date":"2021-06-11","current":-35.251344,"twenty":-30.240841,"median":-13.453601,"eighty":-7.522498,"marketCap":9102743037},{"date":"2021-06-18","current":-34.911997,"twenty":-30.240841,"median":-13.453601,"eighty":-7.522498,"marketCap":9015115553},{"date":"2021-06-25","current":-39.075782,"twenty":-30.240841,"median":-13.453601,"eighty":-7.522498,"marketCap":10090304782},{"date":"2021-07-02","current":-39.656065,"twenty":-30.335509,"median":-13.459287,"eighty":-7.528637,"marketCap":10240147780},{"date":"2021-07-09","current":-41.0406,"twenty":-30.335509,"median":-13.459287,"eighty":-7.528637,"marketCap":10597667914},{"date":"2021-07-16","current":-38.386908,"twenty":-30.335509,"median":-13.459287,"eighty":-7.528637,"marketCap":9912420990},{"date":"2021-07-23","current":-40.672181,"twenty":-30.335509,"median":-13.459287,"eighty":-7.528637,"marketCap":10502533176},{"date":"2021-07-30","current":-41.157059,"twenty":-30.335509,"median":-13.459287,"eighty":-7.528637,"marketCap":10627740467},{"date":"2021-08-06","current":-34.965989,"twenty":-30.335509,"median":-13.459287,"eighty":-7.528637,"marketCap":11000754814},{"date":"2021-08-13","current":-30.08029,"twenty":-30.410494,"median":-13.459287,"eighty":-7.528637,"marketCap":9463650199},{"date":"2021-08-20","current":-32.199712,"twenty":-30.516098,"median":-13.459287,"eighty":-7.528637,"marketCap":10130447869},{"date":"2021-08-27","current":-35.16571,"twenty":-30.72537,"median":-13.459287,"eighty":-7.528637,"marketCap":11063589475},{"date":"2021-09-03","current":-36.891653,"twenty":-30.923791,"median":-13.459287,"eighty":-7.528637,"marketCap":11606593485},{"date":"2021-09-10","current":-35.815547,"twenty":-31.143678,"median":-13.459287,"eighty":-7.528637,"marketCap":11268036581},{"date":"2021-09-17","current":-37.666687,"twenty":-31.676665,"median":-13.459287,"eighty":-7.528637,"marketCap":11850429483},{"date":"2021-09-24","current":-35.210423,"twenty":-32.197413,"median":-13.459287,"eighty":-7.528637,"marketCap":11077656937},{"date":"2021-10-01","current":-33.502366,"twenty":-32.698862,"median":-13.459287,"eighty":-7.528637,"marketCap":10540279911},{"date":"2021-10-08","current":-34.003158,"twenty":-33.089031,"median":-13.459287,"eighty":-7.528637,"marketCap":10697835479},{"date":"2021-10-15","current":-33.01946,"twenty":-33.149682,"median":-13.459287,"eighty":-7.528637,"marketCap":10388351328},{"date":"2021-10-22","current":-34.259515,"twenty":-33.349004,"median":-13.459287,"eighty":-7.528637,"marketCap":10778488924},{"date":"2021-10-29","current":-34.152203,"twenty":-33.508238,"median":-13.459287,"eighty":-7.528637,"marketCap":10744727017},{"date":"2021-11-05","current":-26.916413,"twenty":-33.519062,"median":-13.459287,"eighty":-7.528637,"marketCap":10970160811},{"date":"2021-11-12","current":-26.700561,"twenty":-33.519062,"median":-13.459287,"eighty":-7.528637,"marketCap":10882187632},{"date":"2021-11-19","current":-23.947878,"twenty":-33.519062,"median":-13.493405,"eighty":-7.528637,"marketCap":9760293114},{"date":"2021-11-26","current":-21.970403,"twenty":-33.519062,"median":-13.493405,"eighty":-7.528637,"marketCap":8954345282},{"date":"2021-12-03","current":-20.090409,"twenty":-33.519062,"median":-13.521836,"eighty":-7.528637,"marketCap":8188127272},{"date":"2021-12-10","current":-20.751888,"twenty":-33.519062,"median":-13.624706,"eighty":-7.528637,"marketCap":8457722498},{"date":"2021-12-17","current":-22.197859,"twenty":-33.519062,"median":-13.673053,"eighty":-7.528637,"marketCap":9047048202},{"date":"2021-12-23","current":-21.770799,"twenty":-33.519062,"median":-13.799554,"eighty":-7.528637,"marketCap":8872993740},{"date":"2021-12-31","current":-21.675638,"twenty":-33.519062,"median":-14.003992,"eighty":-7.528637,"marketCap":8834209866},{"date":"2022-01-07","current":-17.44217,"twenty":-33.517471,"median":-14.084691,"eighty":-7.534776,"marketCap":7108800422},{"date":"2022-01-14","current":-15.636447,"twenty":-33.517471,"median":-14.236591,"eighty":-7.534776,"marketCap":6372852753},{"date":"2022-01-21","current":-14.561833,"twenty":-33.517471,"median":-14.369828,"eighty":-7.534776,"marketCap":5934878755},{"date":"2022-01-28","current":-15.19546,"twenty":-33.517471,"median":-14.525846,"eighty":-7.534776,"marketCap":6193122603},{"date":"2022-02-04","current":-16.18884,"twenty":-33.515881,"median":-14.581583,"eighty":-7.540915,"marketCap":6597988416},{"date":"2022-02-11","current":-16.149383,"twenty":-33.515881,"median":-14.752152,"eighty":-7.540915,"marketCap":6581907297},{"date":"2022-02-18","current":-14.828745,"twenty":-33.515881,"median":-14.922089,"eighty":-7.540915,"marketCap":6043662794},{"date":"2022-02-25","current":-13.548029,"twenty":-33.515881,"median":-14.922089,"eighty":-7.540915,"marketCap":6390821912},{"date":"2022-03-04","current":-11.431023,"twenty":-33.515881,"median":-14.922089,"eighty":-7.540915,"marketCap":5392196319},{"date":"2022-03-11","current":-7.889187,"twenty":-33.515881,"median":-14.922089,"eighty":-7.510563,"marketCap":3721455604},{"date":"2022-03-18","current":-8.020741,"twenty":-33.515881,"median":-14.922089,"eighty":-7.480978,"marketCap":3783511687},{"date":"2022-03-25","current":-8.034908,"twenty":-33.515881,"median":-14.922089,"eighty":-7.480978,"marketCap":3790194650},{"date":"2022-04-01","current":-8.682558,"twenty":-33.515881,"median":-14.922089,"eighty":-7.480978,"marketCap":4095701524},{"date":"2022-04-08","current":-8.674462,"twenty":-33.515881,"median":-14.922089,"eighty":-7.480978,"marketCap":4091882688},{"date":"2022-04-14","current":-8.063362,"twenty":-33.515881,"median":-14.922089,"eighty":-7.480978,"marketCap":3803616864},{"date":"2022-04-22","current":-7.404337,"twenty":-33.515881,"median":-14.922089,"eighty":-7.473905,"marketCap":3492744332},{"date":"2022-04-29","current":-7.165619,"twenty":-33.515881,"median":-14.922089,"eighty":-7.430807,"marketCap":3380137253},{"date":"2022-05-06","current":-6.359141,"twenty":-33.515881,"median":-14.922089,"eighty":-7.412499,"marketCap":3475003671},{"date":"2022-05-13","current":-6.027789,"twenty":-33.515881,"median":-14.922089,"eighty":-7.319943,"marketCap":3293933635},{"date":"2022-05-20","current":-7.042996,"twenty":-33.515881,"median":-14.922089,"eighty":-7.226042,"marketCap":3848701406},{"date":"2022-05-27","current":-7.259785,"twenty":-33.515881,"median":-14.922089,"eighty":-7.145064,"marketCap":3967167440},{"date":"2022-06-03","current":-6.517767,"twenty":-33.515881,"median":-14.922089,"eighty":-7.096379,"marketCap":3561686136},{"date":"2022-06-10","current":-6.027789,"twenty":-33.515881,"median":-14.922089,"eighty":-7.006366,"marketCap":3293933635},{"date":"2022-06-17","current":-5.909701,"twenty":-33.515881,"median":-14.922089,"eighty":-6.933141,"marketCap":3229403356},{"date":"2022-06-24","current":-7.293272,"twenty":-33.517471,"median":-14.947115,"eighty":-6.885533,"marketCap":3985467071},{"date":"2022-07-01","current":-6.508955,"twenty":-33.517471,"median":-14.947115,"eighty":-6.858285,"marketCap":3556870443},{"date":"2022-07-08","current":-7.134646,"twenty":-33.517471,"median":-14.947115,"eighty":-6.849894,"marketCap":3898784607},{"date":"2022-07-15","current":-8.075828,"twenty":-33.517471,"median":-14.947115,"eighty":-6.843127,"marketCap":4413100561},{"date":"2022-07-22","current":-7.896051,"twenty":-33.517471,"median":-14.947115,"eighty":-6.843127,"marketCap":4314860435},{"date":"2022-07-29","current":-8.283804,"twenty":-33.517471,"median":-14.947115,"eighty":-6.858285,"marketCap":4526750903},{"date":"2022-08-05","current":-8.670158,"twenty":-33.517471,"median":-14.947115,"eighty":-6.89196,"marketCap":4990395319},{"date":"2022-08-12","current":-9.293425,"twenty":-33.517471,"median":-14.947115,"eighty":-6.931418,"marketCap":5349137551},{"date":"2022-08-19","current":-8.484862,"twenty":-33.517471,"median":-14.947115,"eighty":-6.931418,"marketCap":4883742223},{"date":"2022-08-26","current":-8.176597,"twenty":-33.517471,"median":-14.947115,"eighty":-6.931418,"marketCap":4706310254},{"date":"2022-09-02","current":-8.026676,"twenty":-33.517471,"median":-14.947115,"eighty":-6.931418,"marketCap":4620018204},{"date":"2022-09-09","current":-8.914411,"twenty":-33.517471,"median":-14.947115,"eighty":-6.931418,"marketCap":5130983491},{"date":"2022-09-16","current":-8.178282,"twenty":-33.517471,"median":-14.947115,"eighty":-6.931418,"marketCap":4707279828},{"date":"2022-09-23","current":-7.351189,"twenty":-33.517471,"median":-14.947115,"eighty":-6.931418,"marketCap":4231219190},{"date":"2022-09-30","current":-7.38151,"twenty":-33.517471,"median":-14.947115,"eighty":-6.931418,"marketCap":4248671515},{"date":"2022-10-07","current":-7.204636,"twenty":-33.517471,"median":-14.947115,"eighty":-6.931418,"marketCap":4146866287},{"date":"2022-10-14","current":-6.992389,"twenty":-33.517471,"median":-14.947115,"eighty":-6.89196,"marketCap":4024700013},{"date":"2022-10-21","current":-7.341082,"twenty":-33.517471,"median":-14.947115,"eighty":-6.89196,"marketCap":4225401748},{"date":"2022-10-28","current":-8.02836,"twenty":-33.517471,"median":-14.947115,"eighty":-6.89196,"marketCap":4620987777},{"date":"2022-11-04","current":-7.485949,"twenty":-33.517471,"median":-14.947115,"eighty":-6.89196,"marketCap":4308785078},{"date":"2022-11-11","current":-7.231829,"twenty":-33.517471,"median":-14.947115,"eighty":-6.89196,"marketCap":3947060103},{"date":"2022-11-18","current":-7.115834,"twenty":-33.517471,"median":-14.947115,"eighty":-6.940033,"marketCap":3883750865},{"date":"2022-11-25","current":-7.507384,"twenty":-33.517471,"median":-14.947115,"eighty":-6.98144,"marketCap":4097455292},{"date":"2022-12-02","current":-8.358408,"twenty":-33.517471,"median":-14.947115,"eighty":-7.047144,"marketCap":4561935322},{"date":"2022-12-09","current":-7.619256,"twenty":-33.517471,"median":-14.947115,"eighty":-7.103713,"marketCap":4158513699},{"date":"2022-12-16","current":-8.654068,"twenty":-33.517471,"median":-14.947115,"eighty":-7.123551,"marketCap":4723303971},{"date":"2022-12-23","current":-8.298476,"twenty":-33.517471,"median":-14.947115,"eighty":-7.161528,"marketCap":4529225461},{"date":"2022-12-30","current":-8.024791,"twenty":-33.517471,"median":-14.947115,"eighty":-7.189812,"marketCap":4379850428},{"date":"2023-01-06","current":-7.377533,"twenty":-33.517471,"median":-14.947115,"eighty":-7.218735,"marketCap":4026583926},{"date":"2023-01-13","current":-8.354412,"twenty":-33.517471,"median":-14.947115,"eighty":-7.26207,"marketCap":4559754665},{"date":"2023-01-20","current":-8.172621,"twenty":-33.517471,"median":-14.947115,"eighty":-7.300678,"marketCap":4460534752},{"date":"2023-01-27","current":-8.737972,"twenty":-33.517471,"median":-14.947115,"eighty":-7.336534,"marketCap":4769097777},{"date":"2023-02-03","current":-8.947731,"twenty":-33.517471,"median":-14.947115,"eighty":-7.379919,"marketCap":4883582292},{"date":"2023-02-10","current":-8.544194,"twenty":-33.517471,"median":-14.947115,"eighty":-7.416189,"marketCap":4663335892},{"date":"2023-02-17","current":-9.972555,"twenty":-33.517471,"median":-14.947115,"eighty":-7.455408,"marketCap":5442920920},{"date":"2023-02-24","current":-9.535057,"twenty":-33.517471,"median":-14.947115,"eighty":-7.486806,"marketCap":5204138932},{"date":"2023-03-03","current":-12.019305,"twenty":-33.517471,"median":-14.947115,"eighty":-7.509214,"marketCap":6584163431},{"date":"2023-03-10","current":-11.194167,"twenty":-33.517471,"median":-14.947115,"eighty":-7.563157,"marketCap":6132153587},{"date":"2023-03-17","current":-11.711171,"twenty":-33.517471,"median":-14.947115,"eighty":-7.619544,"marketCap":6415367775},{"date":"2023-03-24","current":-11.715307,"twenty":-33.517471,"median":-14.947115,"eighty":-7.657504,"marketCap":6417633488},{"date":"2023-03-31","current":-11.481621,"twenty":-33.515881,"median":-14.922089,"eighty":-7.682751,"marketCap":6289620676},{"date":"2023-04-06","current":-10.960481,"twenty":-33.515881,"median":-14.922089,"eighty":-7.743114,"marketCap":6004140775},{"date":"2023-04-14","current":-10.76402,"twenty":-33.517471,"median":-14.947115,"eighty":-7.793035,"marketCap":5896519383},{"date":"2023-04-21","current":-11.317515,"twenty":-33.517471,"median":-14.947115,"eighty":-7.862363,"marketCap":6199723557},{"date":"2023-04-28","current":-10.480804,"twenty":-33.517471,"median":-14.947115,"eighty":-7.904687,"marketCap":5741373788},{"date":"2023-05-05","current":-11.044176,"twenty":-33.517471,"median":-14.947115,"eighty":-7.940257,"marketCap":6049988345},{"date":"2023-05-12","current":-10.803534,"twenty":-33.517471,"median":-14.947115,"eighty":-7.964121,"marketCap":5900253134},{"date":"2023-05-19","current":-10.389141,"twenty":-33.517471,"median":-14.947115,"eighty":-8.023171,"marketCap":5673935792},{"date":"2023-05-26","current":-10.096135,"twenty":-33.517471,"median":-14.947115,"eighty":-8.049588,"marketCap":5513913429},{"date":"2023-06-02","current":-10.315889,"twenty":-33.517471,"median":-14.947115,"eighty":-8.070657,"marketCap":5633930201},{"date":"2023-06-09","current":-10.217523,"twenty":-33.517471,"median":-14.947115,"eighty":-8.111891,"marketCap":5580208408},{"date":"2023-06-16","current":-10.615174,"twenty":-33.517471,"median":-14.947115,"eighty":-8.161416,"marketCap":5797381615},{"date":"2023-06-23","current":-11.098633,"twenty":-33.519062,"median":-14.981755,"eighty":-8.186995,"marketCap":6061418514},{"date":"2023-06-30","current":-10.261474,"twenty":-33.520652,"median":-15.016395,"eighty":-8.228393,"marketCap":5604211762},{"date":"2023-07-07","current":-9.857545,"twenty":-33.520652,"median":-15.016395,"eighty":-8.240893,"marketCap":5383609504},{"date":"2023-07-14","current":-10.629824,"twenty":-33.520652,"median":-15.016395,"eighty":-8.255293,"marketCap":5805382733},{"date":"2023-07-21","current":-9.937075,"twenty":-33.520652,"median":-15.016395,"eighty":-8.255293,"marketCap":5427044146},{"date":"2023-07-28","current":-9.485009,"twenty":-33.520652,"median":-15.016395,"eighty":-8.255293,"marketCap":5180152500},{"date":"2023-08-04","current":-9.692773,"twenty":-33.520652,"median":-15.016395,"eighty":-8.255293,"marketCap":4960693259},{"date":"2023-08-11","current":-11.886603,"twenty":-33.520652,"median":-15.016395,"eighty":-8.255293,"marketCap":6083480340},{"date":"2023-08-18","current":-11.581304,"twenty":-33.520652,"median":-15.016395,"eighty":-8.255293,"marketCap":5927230470},{"date":"2023-08-25","current":-12.356808,"twenty":-33.520652,"median":-15.016395,"eighty":-8.255293,"marketCap":6324127950},{"date":"2023-09-01","current":-13.087743,"twenty":-33.520652,"median":-15.016395,"eighty":-8.255293,"marketCap":6698215230},{"date":"2023-09-08","current":-12.803429,"twenty":-33.520652,"median":-15.016395,"eighty":-8.255293,"marketCap":6552705250},{"date":"2023-09-15","current":-12.191619,"twenty":-33.520652,"median":-15.016395,"eighty":-8.255293,"marketCap":6239585299},{"date":"2023-09-22","current":-10.958785,"twenty":-33.520652,"median":-15.016395,"eighty":-8.255293,"marketCap":5608629325},{"date":"2023-09-29","current":-10.502265,"twenty":-33.520652,"median":-15.016395,"eighty":-8.255293,"marketCap":5374985854},{"date":"2023-10-06","current":-9.990129,"twenty":-33.520652,"median":-15.016395,"eighty":-8.255293,"marketCap":5112878203},{"date":"2023-10-13","current":-9.128072,"twenty":-33.520652,"median":-15.016395,"eighty":-8.255293,"marketCap":4671683424},{"date":"2023-10-20","current":-9.600813,"twenty":-33.520652,"median":-15.016395,"eighty":-8.255293,"marketCap":4913628948},{"date":"2023-10-27","current":-9.049282,"twenty":-33.52244,"median":-15.1284,"eighty":-8.246772,"marketCap":4631359170},{"date":"2023-11-03","current":-9.396886,"twenty":-33.52244,"median":-15.1284,"eighty":-8.246772,"marketCap":4809260290},{"date":"2023-11-10","current":-10.921721,"twenty":-33.52244,"median":-15.1284,"eighty":-8.257097,"marketCap":5453685118},{"date":"2023-11-17","current":-12.707118,"twenty":-33.52244,"median":-15.1284,"eighty":-8.29812,"marketCap":6345210643},{"date":"2023-11-24","current":-13.234075,"twenty":-33.52244,"median":-15.1284,"eighty":-8.332622,"marketCap":6608342840},{"date":"2023-12-01","current":-13.462664,"twenty":-33.52244,"median":-15.1284,"eighty":-8.395965,"marketCap":6722486943},{"date":"2023-12-08","current":-13.941497,"twenty":-33.522375,"median":-15.11764,"eighty":-8.447013,"marketCap":6961588802},{"date":"2023-12-15","current":-14.50214,"twenty":-33.522375,"median":-15.11764,"eighty":-8.50829,"marketCap":7241542235},{"date":"2023-12-22","current":-14.506953,"twenty":-33.522375,"median":-15.11764,"eighty":-8.543395,"marketCap":7243945269},{"date":"2023-12-29","current":-14.928037,"twenty":-33.52244,"median":-15.1284,"eighty":-8.574423,"marketCap":7454210723},{"date":"2024-01-05","current":-14.362581,"twenty":-33.522506,"median":-15.140123,"eighty":-8.59472,"marketCap":7171854256},{"date":"2024-01-12","current":-15.161438,"twenty":-33.522506,"median":-15.222152,"eighty":-8.663887,"marketCap":7570757860},{"date":"2024-01-19","current":-16.256257,"twenty":-33.522572,"median":-15.487713,"eighty":-8.720693,"marketCap":8117448041},{"date":"2024-01-26","current":-15.548835,"twenty":-33.522506,"median":-15.685648,"eighty":-8.76478,"marketCap":7764202078},{"date":"2024-02-02","current":-16.407847,"twenty":-33.522506,"median":-15.853459,"eighty":-8.807815,"marketCap":8193143604},{"date":"2024-02-09","current":-16.759152,"twenty":-33.522506,"median":-15.970036,"eighty":-8.921075,"marketCap":8368565069},{"date":"2024-02-16","current":-16.771183,"twenty":-33.522506,"median":-16.106271,"eighty":-9.06504,"marketCap":8374572653},{"date":"2024-02-23","current":-17.120081,"twenty":-33.522506,"median":-16.234705,"eighty":-9.177597,"marketCap":8548792601},{"date":"2024-03-01","current":-24.020986,"twenty":-33.52244,"median":-16.265935,"eighty":-9.288372,"marketCap":10444348781},{"date":"2024-03-08","current":-25.456857,"twenty":-33.52244,"median":-16.397728,"eighty":-9.412258,"marketCap":11068667005},{"date":"2024-03-15","current":-24.359818,"twenty":-33.52244,"median":-16.524726,"eighty":-9.473086,"marketCap":10591673391},{"date":"2024-03-22","current":-25.515181,"twenty":-33.52244,"median":-16.666007,"eighty":-9.473086,"marketCap":11094026159},{"date":"2024-03-28","current":-25.12358,"twenty":-33.52244,"median":-16.771183,"eighty":-9.506648,"marketCap":10923757553},{"date":"2024-04-05","current":-25.651269,"twenty":-33.522506,"median":-16.897683,"eighty":-9.504871,"marketCap":11153197519},{"date":"2024-04-12","current":-26.859401,"twenty":-33.522506,"median":-17.04911,"eighty":-9.504871,"marketCap":11678494284},{"date":"2024-04-19","current":-24.240394,"twenty":-33.522506,"median":-17.32188,"eighty":-9.509487,"marketCap":10539747504},{"date":"2024-04-26","current":-25.662794,"twenty":-33.52244,"median":-17.509994,"eighty":-9.515879,"marketCap":11158208684},{"date":"2024-05-03","current":-26.348785,"twenty":-33.52244,"median":-17.641524,"eighty":-9.515879,"marketCap":11456478066},{"date":"2024-05-10","current":-26.863278,"twenty":-33.52244,"median":-17.784016,"eighty":-9.540149,"marketCap":11680180102},{"date":"2024-05-17","current":-36.458116,"twenty":-33.787846,"median":-17.921026,"eighty":-9.540149,"marketCap":13324092299},{"date":"2024-05-24","current":-36.125456,"twenty":-34.008663,"median":-18.058037,"eighty":-9.540149,"marketCap":13202517631},{"date":"2024-05-31","current":-37.002467,"twenty":-34.140021,"median":-18.392344,"eighty":-9.540149,"marketCap":13523032663},{"date":"2024-06-07","current":-36.70005,"twenty":-34.258532,"median":-18.655405,"eighty":-9.540149,"marketCap":13412510238},{"date":"2024-06-14","current":-37.2276,"twenty":-34.329835,"median":-18.737635,"eighty":-9.537603,"marketCap":13605310468},{"date":"2024-06-21","current":-36.02129,"twenty":-34.40484,"median":-19.134165,"eighty":-9.535057,"marketCap":13164448796},{"date":"2024-06-28","current":-36.965505,"twenty":-34.55691,"median":-19.461689,"eighty":-9.515879,"marketCap":13509524366},{"date":"2024-07-05","current":-37.513217,"twenty":-34.700961,"median":-19.757764,"eighty":-9.515879,"marketCap":13709692758},{"date":"2024-07-12","current":-37.234321,"twenty":-34.954065,"median":-20.225015,"eighty":-9.515879,"marketCap":13607766522},{"date":"2024-07-15","current":-37.499776,"twenty":-35.010965,"median":-20.296796,"eighty":-9.515879,"marketCap":13704780650},{"date":"2024-08-02","current":-34.610008,"twenty":-35.150895,"median":-20.900431,"eighty":-9.481035,"marketCap":12648677482},{"date":"2024-08-09","current":-45.274781,"twenty":-35.174014,"median":-21.147078,"eighty":-9.481035,"marketCap":13225850143},{"date":"2024-08-16","current":-51.759031,"twenty":-35.318163,"median":-21.21009,"eighty":-9.481035,"marketCap":15120055062},{"date":"2024-08-23","current":-51.91145,"twenty":-35.475972,"median":-21.346987,"eighty":-9.481035,"marketCap":15164580377},{"date":"2024-08-30","current":-49.21871,"twenty":-35.632418,"median":-21.477813,"eighty":-9.481035,"marketCap":14377966470},{"date":"2024-09-06","current":-49.747944,"twenty":-35.764226,"median":-21.522486,"eighty":-9.481035,"marketCap":14532568260},{"date":"2024-09-13","current":-52.974151,"twenty":-35.800035,"median":-21.675638,"eighty":-9.481035,"marketCap":15475020771},{"date":"2024-09-20","current":-53.825158,"twenty":-35.90916,"median":-21.812856,"eighty":-9.481035,"marketCap":15723620450},{"date":"2024-09-27","current":-52.436449,"twenty":-36.238359,"median":-22.041859,"eighty":-9.481035,"marketCap":15317945353},{"date":"2024-10-04","current":-53.473747,"twenty":-36.394406,"median":-22.111173,"eighty":-9.481035,"marketCap":15620964861},{"date":"2024-10-11","current":-53.240884,"twenty":-36.516639,"median":-22.234052,"eighty":-9.481035,"marketCap":15552940074},{"date":"2024-10-18","current":-51.801369,"twenty":-36.77599,"median":-22.323397,"eighty":-9.481035,"marketCap":15132423205},{"date":"2024-10-25","current":-50.454999,"twenty":-36.842357,"median":-22.342542,"eighty":-9.481035,"marketCap":14739116251},{"date":"2024-10-31","current":-53.655803,"twenty":-36.91443,"median":-22.342542,"eighty":-9.481035,"marketCap":15674147877},{"date":"2024-11-08","current":-55.205399,"twenty":-37.073335,"median":-22.351571,"eighty":-9.477061,"marketCap":16126821918},{"date":"2024-11-15","current":-92.924855,"twenty":-37.2276,"median":-22.351571,"eighty":-9.477061,"marketCap":19949665505},{"date":"2024-11-22","current":-104.147664,"twenty":-37.385002,"median":-22.351571,"eighty":-9.477061,"marketCap":22359045397},{"date":"2024-11-29","current":-103.176046,"twenty":-37.495744,"median":-22.351571,"eighty":-9.477061,"marketCap":22150452508},{"date":"2024-12-06","current":-103.938582,"twenty":-37.521457,"median":-22.431501,"eighty":-9.477061,"marketCap":22314158320},{"date":"2024-12-13","current":-102.358164,"twenty":-37.640694,"median":-22.488937,"eighty":-9.477061,"marketCap":21974864823},{"date":"2024-12-20","current":-97.217195,"twenty":-37.835796,"median":-22.575477,"eighty":-9.477061,"marketCap":20871170801},{"date":"2024-12-27","current":-98.170365,"twenty":-38.236466,"median":-22.658439,"eighty":-9.477061,"marketCap":21075803066},{"date":"2025-01-03","current":-98.760716,"twenty":-38.438103,"median":-22.746097,"eighty":-9.477061,"marketCap":21202543049},{"date":"2025-01-10","current":-108.60604,"twenty":-38.59495,"median":-22.930338,"eighty":-9.473086,"marketCap":23316196313},{"date":"2025-01-17","current":-103.618808,"twenty":-38.794278,"median":-23.043761,"eighty":-9.473086,"marketCap":22245507496},{"date":"2025-01-24","current":-105.660437,"twenty":-38.938451,"median":-23.043761,"eighty":-9.473086,"marketCap":22683816605},{"date":"2025-01-31","current":-108.396958,"twenty":-39.088152,"median":-23.299806,"eighty":-9.473086,"marketCap":23271309236},{"date":"2025-02-07","current":-107.702066,"twenty":-39.190877,"median":-23.535931,"eighty":-9.473086,"marketCap":23122125714},{"date":"2025-02-14","current":-104.990143,"twenty":-39.353723,"median":-23.695475,"eighty":-9.473086,"marketCap":22539913915},{"date":"2025-02-21","current":-103.428174,"twenty":-39.499298,"median":-24.020986,"eighty":-9.473086,"marketCap":22204581043},{"date":"2025-02-28","current":-108.576455,"twenty":-39.5859,"median":-24.609777,"eighty":-9.473086,"marketCap":20675779993},{"date":"2025-03-07","current":-100.452906,"twenty":-39.725306,"median":-24.765307,"eighty":-9.469112,"marketCap":19128845036},{"date":"2025-03-14","current":-101.169919,"twenty":-39.834895,"median":-25.012487,"eighty":-9.469112,"marketCap":19265383081},{"date":"2025-03-21","current":-106.224511,"twenty":-39.955314,"median":-25.099972,"eighty":-9.469112,"marketCap":20227908711},{"date":"2025-03-28","current":-105.280325,"twenty":-40.018318,"median":-25.326816,"eighty":-9.469112,"marketCap":20048111087},{"date":"2025-04-04","current":-98.472244,"twenty":-40.36546,"median":-25.520736,"eighty":-9.469112,"marketCap":18751675582},{"date":"2025-04-11","current":-101.716554,"twenty":-40.719115,"median":-25.662794,"eighty":-9.473086,"marketCap":19369476443},{"date":"2025-04-17","current":-106.607865,"twenty":-40.879236,"median":-25.724646,"eighty":-9.473086,"marketCap":20300909251},{"date":"2025-04-25","current":-109.667596,"twenty":-41.100522,"median":-26.110667,"eighty":-9.469112,"marketCap":20883561704},{"date":"2025-05-02","current":-108.061421,"twenty":-41.601833,"median":-26.275822,"eighty":-9.469112,"marketCap":20577704104},{"date":"2025-05-09","current":-116.470159,"twenty":-41.960275,"median":-26.447637,"eighty":-9.469112,"marketCap":22101726719},{"date":"2025-05-16","current":-107.502827,"twenty":-43.568473,"median":-26.447637,"eighty":-9.469112,"marketCap":20400059052},{"date":"2025-05-23","current":-109.719084,"twenty":-44.421773,"median":-26.447637,"eighty":-9.469112,"marketCap":20820622518},{"date":"2025-05-30","current":-113.727054,"twenty":-44.762204,"median":-26.447637,"eighty":-9.469112,"marketCap":21581186969},{"date":"2025-06-06","current":-119.095,"twenty":-45.361787,"median":-26.486791,"eighty":-9.469112,"marketCap":22599824455},{"date":"2025-06-13","current":-118.260306,"twenty":-47.588167,"median":-26.772575,"eighty":-9.469112,"marketCap":22441430423},{"date":"2025-06-20","current":-123.031014,"twenty":-48.257622,"median":-26.744073,"eighty":-9.465138,"marketCap":23346734248},{"date":"2025-06-27","current":-121.009039,"twenty":-49.21871,"median":-26.744073,"eighty":-9.465138,"marketCap":22963038358},{"date":"2025-07-03","current":-116.396636,"twenty":-49.815685,"median":-26.744073,"eighty":-9.465138,"marketCap":22087774780},{"date":"2025-07-11","current":-117.547938,"twenty":-50.069717,"median":-26.744073,"eighty":-9.465138,"marketCap":22306249308},{"date":"2025-07-18","current":-103.171054,"twenty":-50.268709,"median":-26.744073,"eighty":-9.465138,"marketCap":19578048640},{"date":"2025-07-25","current":-101.505263,"twenty":-50.391491,"median":-26.744073,"eighty":-9.465138,"marketCap":19261943307},{"date":"2025-08-01","current":-96.176894,"twenty":-50.785241,"median":-26.744073,"eighty":-9.465138,"marketCap":18250815882},{"date":"2025-08-08","current":-76.188225,"twenty":-51.299648,"median":-26.801077,"eighty":-9.465138,"marketCap":19293677560},{"date":"2025-08-15","current":-85.870508,"twenty":-51.822539,"median":-26.863278,"eighty":-9.465138,"marketCap":21745589914},{"date":"2025-08-22","current":-87.77284,"twenty":-52.110442,"median":-26.863278,"eighty":-9.465138,"marketCap":22227330766},{"date":"2025-08-29","current":-90.986752,"twenty":-52.436449,"median":-26.863278,"eighty":-9.465138,"marketCap":23041212035},{"date":"2025-09-05","current":-90.271345,"twenty":-52.678198,"median":-26.861339,"eighty":-9.464926,"marketCap":22860044535},{"date":"2025-09-12","current":-94.200663,"twenty":-53.228183,"median":-26.863278,"eighty":-9.465138,"marketCap":23855093303},{"date":"2025-09-19","current":-97.479611,"twenty":-53.568462,"median":-26.863278,"eighty":-9.465138,"marketCap":24685444345},{"date":"2025-09-26","current":-88.699617,"twenty":-53.757416,"median":-26.863278,"eighty":-9.465138,"marketCap":22462025027},{"date":"2025-10-03","current":-86.829804,"twenty":-53.889991,"median":-26.863278,"eighty":-9.465138,"marketCap":21988519062},{"date":"2025-10-10","current":-93.791472,"twenty":-54.100359,"median":-26.863278,"eighty":-9.465138,"marketCap":23751470983},{"date":"2025-10-17","current":-97.848154,"twenty":-54.338319,"median":-26.863278,"eighty":-9.465138,"marketCap":24778773057},{"date":"2025-10-24","current":-105.685112,"twenty":-55.065681,"median":-26.863278,"eighty":-9.465138,"marketCap":26763380670},{"date":"2025-10-31","current":-104.720396,"twenty":-55.873505,"median":-26.863278,"eighty":-9.465138,"marketCap":26519079041},{"date":"2025-11-07","current":-88.287584,"twenty":-76.188225,"median":-26.863278,"eighty":-9.465138,"marketCap":27297549840},{"date":"2025-11-14","current":-89.574217,"twenty":-85.870508,"median":-26.863278,"eighty":-9.465138,"marketCap":27695362691},{"date":"2025-11-21","current":-100.680045,"twenty":-87.241705,"median":-26.863278,"eighty":-9.465138,"marketCap":31129162580},{"date":"2025-11-28","current":-106.598988,"twenty":-88.054667,"median":-26.863278,"eighty":-9.465138,"marketCap":32959234386},{"date":"2025-12-05","current":-108.049709,"twenty":-88.390692,"median":-26.863278,"eighty":-9.465138,"marketCap":33407781397},{"date":"2025-12-12","current":-103.135112,"twenty":-89.751049,"median":-26.863278,"eighty":-9.465138,"marketCap":31888242138},{"date":"2025-12-19","current":-100.541392,"twenty":-90.721184,"median":-26.863278,"eighty":-9.465138,"marketCap":31086292554},{"date":"2025-12-26","current":-105.372962,"twenty":-91.185634,"median":-26.863278,"eighty":-9.465138,"marketCap":32580160844},{"date":"2026-01-02","current":-102.487441,"twenty":-91.740097,"median":-26.863278,"eighty":-9.465138,"marketCap":31687989504},{"date":"2026-01-09","current":-107.17138,"twenty":-92.274791,"median":-26.863278,"eighty":-9.465138,"marketCap":33136211819},{"date":"2026-01-16","current":-107.520327,"twenty":-93.515715,"median":-26.863278,"eighty":-9.465138,"marketCap":33244102306},{"date":"2026-01-23","current":-108.670061,"twenty":-93.871998,"median":-26.863278,"eighty":-9.465138,"marketCap":33599587631},{"date":"2026-01-30","current":-103.55665,"twenty":-94.851033,"median":-26.863278,"eighty":-9.465138,"marketCap":32018577024},{"date":"2026-02-06","current":-88.167205,"twenty":-95.368174,"median":-26.863278,"eighty":-9.465138,"marketCap":27260329877}],"updateTime":1770570024349},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NTRA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609625085","title":"Natera Launches EDEN Study to Assess Early Risk of Preeclampsia in Pregnancy","url":"https://stock-news.laohu8.com/highlight/detail?id=2609625085","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609625085?lang=en_us&edition=fundamental","pubTime":"2026-02-06 19:01","pubTimestamp":1770375678,"startTime":"0","endTime":"0","summary":"Natera Inc. has announced the launch of the EDEN study, a large, multi-center prospective clinical trial designed to evaluate the company's non-invasive prenatal screening test for early risk assessment of preeclampsia and other serious pregnancy complications. The EDEN study aims to enroll up to 7,500 pregnant participants in the United States between 9 and 15 weeks' gestation. The trial will assess the performance of Natera's integrated prenatal risk assessment test, which combines cell-free DNA , additional analytes, and clinical data. The goal is to identify pregnancies at increased risk for preeclampsia—including earlier-onset and more severe disease—as well as other adverse pregnancy outcomes. Results from the EDEN study have not yet been presented.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nNDL2TS9F2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106261612.USD","LU0345770308.USD","LU0053671581.USD","LU2065731478.USD","LU2264538146.SGD","LU2065171402.SGD","LU0963586101.USD","LU1064131342.USD","LU0345770993.USD","LU1988902786.USD","LU2065169927.USD","NTRA","LU0012050646.USD","LU2324357040.USD","LU2065170008.USD","BK4139","LU2065171311.SGD"],"gpt_icon":0},{"id":"2609453093","title":"Natera Inc. Chief Legal Officer Daniel Rabinowitz Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2609453093","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609453093?lang=en_us&edition=fundamental","pubTime":"2026-02-05 10:05","pubTimestamp":1770257134,"startTime":"0","endTime":"0","summary":"Daniel Rabinowitz, who serves as Secretary and Chief Legal Officer, reported a disposal of common shares of Natera Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Natera Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 04, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDL26WLdz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Natera Inc. Chief Legal Officer Daniel Rabinowitz Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","LU0012050646.USD","NTRA","LU0106261612.USD","LU2065171311.SGD","LU0345770993.USD","BK4139","LU2065731478.USD","LU0345770308.USD","LU2065169927.USD","LU2065170008.USD","LU0963586101.USD","LU1064131342.USD","LU1988902786.USD","LU0053671581.USD","LU2264538146.SGD","LU2065171402.SGD"],"gpt_icon":0},{"id":"2608580216","title":"Natera on Track for Longest Losing Streak Since September 2023 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2608580216","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608580216?lang=en_us&edition=fundamental","pubTime":"2026-02-04 03:34","pubTimestamp":1770147240,"startTime":"0","endTime":"0","summary":"Natera, Inc.  is currently at $225.90, down $5.20 or 2.25%. --Would be lowest close since Dec. 18, 2025, when it closed at $224.74. --On pace for largest percent decrease since Jan. 16, 2026, when it fell 3.78%. --Currently down eight consecutive days; down 7% over this period. --Longest losing streak since Sept. 26, 2023, when it fell for nine straight trading days. --Up 29.65% from 52 weeks ago , when it closed at $174.24. --Down 11.2% from its 52-week closing high of $254.40 on Jan. 7, 2026. --Up 70.84% from its 52-week closing low of $132.23 on April 8, 2025. --Traded as low as $224.21; lowest intraday level since Dec. 18, 2025, when it hit $223.98. --Down 2.98% at today's intraday low; largest intraday percent decrease since Jan. 16, 2026, when it fell as much as 4.25%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065170008.USD","LU0012050646.USD","LU2065731478.USD","LU0345770308.USD","LU0963586101.USD","LU0053671581.USD","BK4139","LU1064131342.USD","LU2065171402.SGD","LU2065169927.USD","NTRA","LU2264538146.SGD","LU2065171311.SGD","LU2324357040.USD","LU1988902786.USD","LU0345770993.USD","LU0106261612.USD"],"gpt_icon":0},{"id":"2608020498","title":"Exploring US High Growth Tech Stocks This February 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2608020498","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608020498?lang=en_us&edition=fundamental","pubTime":"2026-02-04 01:08","pubTimestamp":1770138521,"startTime":"0","endTime":"0","summary":"As February 2026 begins, the United States stock market has shown a strong start with major indices like the Dow Jones Industrial Average and S&P 500 posting significant gains, reflecting positive investor sentiment despite ongoing economic uncertainties such as delayed jobs data due to a government shutdown. In this environment, identifying high growth tech stocks requires careful consideration of factors such as innovation potential and resilience in adapting to evolving market dynamics.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/8041000-choice2-main-header/1585186556238","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8041000-choice2-main-header/1585186556238"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/software/nyse-pcor/procore-technologies/news/exploring-us-high-growth-tech-stocks-this-february-2026","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/software/nyse-pcor/procore-technologies/news/exploring-us-high-growth-tech-stocks-this-february-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1064131342.USD","BK4535","LU2065170008.USD","BK4023","LU2065171311.SGD","PCOR","LU0345770993.USD","LU2324357040.USD","LU0106261612.USD","BK4139","LU2065169927.USD","LU0053671581.USD","LU2065731478.USD","BK4613","LU2264538146.SGD","LU0345770308.USD","BK7095","BK4539","MRD.AU","LU2065171402.SGD","LU0012050646.USD","LU0963586101.USD","LU1988902786.USD","NTRA","KVYO"],"gpt_icon":0},{"id":"2608863947","title":"BRIEF-Natera Submits Signatera™ CDx PMA To FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2608863947","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608863947?lang=en_us&edition=fundamental","pubTime":"2026-02-02 19:29","pubTimestamp":1770031752,"startTime":"0","endTime":"0","summary":"BRIEF-Natera Submits Signatera™ CDx PMA To FDAFeb 2 (Reuters) - Natera Inc NTRA.O:NATERA SUBMITS SIGNATERA™ CDX PMA TO FDANATERA INC - SUBMISSION SUPPORTED BY PHASE 3 IMVIGOR011 TRIAL DATASource text: ID:nBwFlCBqaFurther company coverage: NTRA.O ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nTUA1CKBKX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065169927.USD","LU0012050646.USD","LU2264538146.SGD","LU0963586101.USD","LU0345770308.USD","LU0345770993.USD","LU0053671581.USD","LU1064131342.USD","BK4139","LU2065171402.SGD","LU2065731478.USD","LU1988902786.USD","LU2324357040.USD","LU2065170008.USD","LU2065171311.SGD","NTRA","LU0106261612.USD"],"gpt_icon":0},{"id":"2608868428","title":"Natera Submits Signatera CDx Premarket Approval Application to FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2608868428","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608868428?lang=en_us&edition=fundamental","pubTime":"2026-02-02 19:00","pubTimestamp":1770030053,"startTime":"0","endTime":"0","summary":"Natera Inc. has submitted a premarket approval  application to the U.S. Food and Drug Administration  for its Signatera CDx test, intended for the detection of molecular residual disease  in patients with muscle-invasive bladder cancer  who may benefit from treatment with atezolizumab . The submission is supported by data from the phase 3 IMvigor011 clinical trial, which demonstrated improved disease-free survival and overall survival in Signatera-positive patients treated with atezolizumab, compared to placebo. If approved, Signatera CDx could become the first companion diagnostic MRD test to guide treatment decisions for patients with muscle-invasive bladder cancer.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Natera Inc. published","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nNDL7YjsbH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065731478.USD","LU2065169927.USD","LU2324357040.USD","LU2264538146.SGD","BK4139","LU0345770308.USD","LU0012050646.USD","LU0963586101.USD","LU2065171402.SGD","LU1064131342.USD","LU0053671581.USD","LU2065170008.USD","LU0106261612.USD","NTRA","LU2065171311.SGD","LU0345770993.USD","LU1988902786.USD"],"gpt_icon":0},{"id":"2608868151","title":"Natera Submits Signatera™ Cdx Pma to FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2608868151","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608868151?lang=en_us&edition=fundamental","pubTime":"2026-02-02 19:00","pubTimestamp":1770030001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nTUA1CKBKX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2324357040.USD","LU2065169927.USD","NTRA","BK4139","LU2065171402.SGD","LU0053671581.USD","LU1064131342.USD","LU0345770993.USD","LU0963586101.USD","LU2065171311.SGD","LU2065731478.USD","LU0012050646.USD","LU2065170008.USD","LU1988902786.USD","LU0345770308.USD","LU0106261612.USD","LU2264538146.SGD"],"gpt_icon":0},{"id":"2608186813","title":"Natera Inc - Submission Supported by Phase 3 Imvigor011 Trial Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2608186813","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608186813?lang=en_us&edition=fundamental","pubTime":"2026-02-02 19:00","pubTimestamp":1770030001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nTUA1CKBKX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2065731478.USD","NTRA","BK4139","LU0345770993.USD","LU0053671581.USD","LU0106261612.USD","LU2264538146.SGD","LU1064131342.USD","LU2065169927.USD","LU0012050646.USD","LU0963586101.USD","LU2065170008.USD","LU2324357040.USD","LU2065171402.SGD","LU2065171311.SGD","LU0345770308.USD","LU1988902786.USD"],"gpt_icon":0},{"id":"2608830848","title":"The Druckenmiller Connection: Meet the Man Behind Bessent and Warsh -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2608830848","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608830848?lang=en_us&edition=fundamental","pubTime":"2026-02-02 14:30","pubTimestamp":1770013800,"startTime":"0","endTime":"0","summary":"If President Donald Trump's pick for Federal Reserve chair, Kevin Warsh, is confirmed by the Senate, it will put Wall Street investor Stanley Druckenmiller in the unusual position of having mentored two of the most powerful financial leaders in Washington, nay the world, in Warsh and Treasury Secretary Scott Bessent, who also worked for Druckenmiller. It also means that Stan, or \"Druck\" -- he is known by both on the Street -- would be in the enviable position of having a direct connection to the heads of both the Fed and Treasury.Druckenmiller, 72, a highly influential, long-short macro investor with a sterling track record, has been critical of fiscal policy and particularly Fed policy in recent years. When asked about his acolytes, he sounds pleased they could be in a position to implement change.\"Stan has been a mentor to many, particularly in his approach to managing risk,\" says Paula Volent, chief investment officer of Rockefeller University. \"He also has a great track record in i","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2750360997.AUD","LU1935043023.USD","LU0511384066.AUD","LU0724617625.USD","LU0354030438.USD","LU1861127337.USD","LU0211328371.USD","LU1674673691.USD","LU0308772762.SGD","LU0979878070.USD","LU1935043536.SGD","LU2403377893.USD","LU0823411888.USD","IE00B19Z9505.USD","SG9999017495.SGD","LU1046421795.USD","LU0107464264.USD","LU0158827781.USD","BK4007","BK4585","LU0127658192.USD","LU1934455863.HKD","LU0077335932.USD","IE0002270589.USD","BK4584","LU2317271919.USD","TEVA","LU2065169927.USD","IE0005OL40V9.USD","LU2023250504.SGD","LU2089283258.USD","LU1861215975.USD","LU2290526834.HKD","AMZY","IE00B775SV38.USD","LU0154236417.USD","LU2092937148.SGD","LU1551013425.SGD","LU2023251221.USD","LU0345774391.USD","IE00B19Z3B42.SGD","LU0823434740.USD","IE0004086264.USD","IE0004445015.USD","BK4220","LU0070217475.USD","LU0957791311.USD","LU0648001328.SGD","LU1037948541.HKD","AZYY","BK4534","LU0276348264.USD","SG9999015952.SGD","LU0289941410.SGD","LU2462157665.USD","LU1244550221.USD","LU0011850046.USD","LU0053687314.USD","LU2543165471.USD","LU2326559502.SGD","IE00BKDWB100.SGD","LU0345770308.USD","LU2456880835.USD","TLTW","LU0048584097.USD","LU0314104364.USD","LU1674673428.USD","LU0889565916.HKD","LU0143863198.USD","LU2087621335.USD","LU1116320737.USD","BK4139","SG9999014906.USD","LU0109392836.USD","LU0210528500.USD","IE000KEQY171.SGD","LU1069344957.HKD","LU0265550359.USD","IE00BWXC8680.SGD","LU1244550577.SGD","LU2362541513.USD","LU2471134523.USD","LU1861220033.SGD","LU0070302665.USD","CPNG","IE0003U64NQ7.SGD","LU2361044865.SGD","LU0868486357.SGD","LU1084165304.USD","LU1988902786.USD","LU1880398471.USD","LU2430703251.USD","LU1496350171.SGD","LU0267386448.USD","SG9999015945.SGD","BK4533","LU1815333072.USD","LU1242518931.SGD","LU0345768153.USD","LU0390134368.USD","BK4535","IE00BJTD4N35.SGD","IE00BMPRXQ63.HKD","LU1064131342.USD","LU1718418525.SGD","LU0320765489.SGD","IE00B4YYXB79.USD","BK4543","LU1934455277.USD","LU2505996681.GBP","LU0056508442.USD","TMF","LU2505996509.AUD","IE00BFSS8Q28.SGD","LU0029864427.USD","LU2463028550.USD","LU0964807845.USD","LU0345768740.USD","LU0251132253.USD","LU1429558221.USD","LU0061474705.USD","LU2756315318.SGD","LU2237957902.USD","IE00B0JY6N72.USD","LU1316542783.SGD","LU2087625088.SGD","BK4503","LU1868836591.USD","LU0256863902.USD","AMZD","LU2242650005.HKD","SGXZ51526630.SGD","SG9999000418.SGD","IE0009G5SDU7.USD","BK4550","LU2092627202.USD","LU0672654240.SGD","SG9999018857.SGD","LU2746668461.USD","LU0820561818.USD","LU0106959298.USD","LU0786609619.USD","LU2083900584.USD","LU2236285917.USD","LU2362541273.HKD","LU0472753341.HKD","LU1066051225.USD","LU0788109477.HKD","LU2452424414.USD","LU1261432733.SGD","LU2471134879.HKD","IE00BFXG0V08.USD","LU0345769128.USD","IE00B0169N27.USD","LU2168564495.EUR","IE00B5949003.HKD","IE0004445239.USD","LU0787776722.HKD","LU1145028129.USD","IE0001KFT4U8.USD","LU0053666078.USD","LU0466842654.USD","IE00B3SWFQ91.USD","MELI","SG9999004303.SGD","LU2552382058.USD","LU0256863811.USD","LU2213496289.HKD","LU1127390331.HKD","LU0203202063.USD","LU2264538146.SGD","SGXZ81514606.USD","LU0354030511.USD","LU0312595415.SGD","BK4566","LU2106854487.HKD","LU0170899867.USD","LU1267930730.SGD","LU1629891620.HKD","LU1153585028.USD","LU0943347566.SGD","LU1989764664.SGD","LU0342679015.USD","IE00B1XK9C88.USD","LU2360032135.SGD","LU1244550494.USD","LU2108987350.USD","LU2211815571.USD","BK4551","LU2552382215.SGD","LU0054578231.USD","IE00BYQQ9H92.USD","SG9999014898.SGD","LU0082616367.USD","LU0823421416.USD","LU1791710582.SGD","IE00BQXX3F31.USD","LU2592432038.USD","LU2552382132.HKD","LU2417539215.USD","LU1633808545.USD","LU1691799644.USD","LU1814569148.SGD","LU2381873111.SGD","LU1868836757.USD","LU0234572021.USD","IE00BFSS7M15.SGD","SG9999014880.SGD","LU0238689110.USD","IE00B775H168.HKD","IE00BK4W5M84.HKD","LU2168564149.EUR","LU2237438978.USD","LU1720051108.HKD","LU0289739343.SGD","LU2361045086.USD","LU2750360641.GBP","LU2125154935.USD","LU0210535034.USD","LU2461242641.AUD","LU2265009873.SGD","IE00B1B80R65.USD","BK4581","AMZW","BK4532","LU1861558580.USD","BK4538","IE00B8HQ1Z84.USD","LU0316494557.USD","LU1116320901.HKD","LU0708995401.HKD","LU0456855351.SGD","BK4598","LU1839511570.USD","LU1868837722.USD","LU2420271590.USD","IE00B3S45H60.SGD","LU0109391861.USD","BK4557","BK4548","LU0289961442.SGD","LU1823568750.SGD","BK4122","LU1119994496.HKD","BK4554","LU0203201768.USD","LU2487616109.SGD","LU2324357040.USD","LU2602419157.SGD","LU2362540622.SGD","INSM","LU1917777945.USD","BK4524","LU0320765992.SGD","LU0965509010.AUD","LU2430703178.SGD","LU0211327993.USD","IE00BJJMRY28.SGD","IE00BJJMRX11.SGD","LU1201861249.SGD","LU0345769631.USD","LU0345770993.USD","IE000ITXATA3.USD","LU2028103732.USD","IE000W1ABFV2.USD","SG9999015986.USD","LU0980610538.SGD","LU2756315664.SGD","LU1201861165.SGD","LU0985320562.USD","LU2125154778.USD","LU1232071149.USD","LU0353189680.USD","LU1366333091.USD","BK4604","LU2430703095.HKD","LU1861559042.SGD","LU1934455194.USD","LU0210533765.USD","SG9999001077.SGD","LU0158827948.USD","LU1935042991.SGD","LU2097829019.USD","IE00B4JS1V06.HKD","LU0310800379.SGD","LU0130102774.USD","BK4507","LU1883839398.USD","LU1880398554.USD","IE00BMPRXN33.USD","LU1037948897.HKD","LU2077746001.SGD","IE00BKVL7J92.USD","LU0640476718.USD","LU2764262908.HKD","IE00BJTD4V19.USD","LU0265550946.USD","LU1267930490.SGD","SG9999015978.USD","LU2860962120.EUR","IE00B7SZLL34.SGD","LU2271345857.HKD","IE00BN29S564.USD","LU0532187761.SGD","SG9999014914.USD","LU0057025933.USD","LU1804176565.USD","LU0683600562.USD","LU1548497426.USD","LU0348723411.USD","LU2275660780.HKD","LU1720051017.SGD","IE00BK4W5L77.USD","LU1983299246.USD","IE00B5TLWC47.USD","NTRA","LU1778281490.HKD","BK4592","IE00B1BXHZ80.USD","LU2764263203.CNY","IE0004091025.USD","LU0072462426.USD","LU0215105999.USD","SG9999002232.USD","LU0528227936.USD","IE00B19Z8X17.USD","LU2065170008.USD","LU0208291251.USD","LU2279701549.SGD","LU2471134952.CNY","LU2720916845.USD","LU0889565833.HKD","LU0096362180.USD","LU1066053197.SGD","IE00B19Z3581.USD","LU1868836914.USD","LU2023250330.USD","BK4561","AMZU","LU0210536198.USD","LU0109394709.USD","LU0320765059.SGD","BK4579","IE000YTNTUN2.SGD","IE00B8L5B284.USD","BK4612","LU0143863784.USD","LU2360106780.USD","IE0009356076.USD","BK4113","LU0494093205.USD","IE00BKPKM429.USD","LU2211817866.USD","HK0000914660.USD","LU0079474960.USD","LU1242518857.USD","LU1791710400.SGD","LU2065171311.SGD","IE00B7KXQ091.USD","IE00BQXX3D17.EUR","LU1803068979.SGD","LU0198837287.USD","LU1074936037.SGD","LU0965508806.USD","LU1066051498.USD","LU1280957306.USD","LU1868837136.USD","LU1935042215.USD","LU1267930573.SGD","LU1551013342.USD","SG9999018865.SGD","LU1914381329.SGD","LU0234570918.USD","IE00BMPRXR70.SGD","LU0061475181.USD","LU0157215616.USD","LU2896262040.SGD","LU0820561909.HKD","LU0053671581.USD","LU0080751232.USD","LU2247934214.USD","LU0642271901.SGD","AMZZ","LU0072461881.USD","BK4559","LU1496350502.SGD","SGXZ23171101.USD","LU0050427557.USD","LU2746668974.SGD","LU0965509283.SGD","LU2168563687.JPY","SGXZ31699556.SGD","LU2360107168.USD","LU0820562030.AUD","LU0069063385.USD","LU1366192091.USD","LU0128525929.USD","LU2250418816.HKD","LU0823434583.USD","IE00BGV7N243.SGD","LU0175139822.USD","LU0861579265.USD","IE00BZ1G4Q59.USD","LU0823421333.USD","LU0719512351.SGD","GB00BDT5M118.USD","LU1852331112.SGD","LU0302445910.USD","LU2355687059.USD","IE00BQXX3C00.GBP","LU0708994859.HKD","LU2063271972.USD","LU2361044949.HKD","LU1323610961.USD","LU2089284900.SGD","LU0431992006.USD","LU2065171402.SGD","LU2237957811.SGD","SG9999002224.SGD","LU0289960550.SGD","IE0034235303.USD","LU0096364046.USD","LU0149725797.USD","LU0061474960.USD","LU1989764748.USD","LU0310799852.SGD","BK4527","LU0345774631.USD","LU1974910355.USD","LU1435385759.SGD","LU0162691827.USD","LU0323591593.USD","LU0417517546.SGD","LU1868837565.USD","LU1066051811.HKD","LU1935042488.USD","LU0456842615.SGD","LU1235294995.USD","LU0097036916.USD","LU1868837300.USD","LU2168564065.EUR","LU2764263039.SGD","LU0965509101.SGD","LU2357305700.SGD","IE00B19Z8W00.USD","LU0130103400.USD","LU2242649171.HKD","LU0689472784.USD","LU0353189763.USD","USAW.SI","LU0882574139.USD","LU2471134796.USD","SGXZ99366536.SGD","LU1868838027.USD","BK4588","IE00BJLML261.HKD","BK4596","LU2168564222.USD","LU2054465674.USD","LU2111349929.HKD","LU1035775433.USD","HK0000914686.HKD","LU0648000940.SGD"],"gpt_icon":1},{"id":"2606197307","title":"Natera Completes Enrollment in ACES-EMB Trial Evaluating Prospera Heart Test for Transplant Rejection Monitoring","url":"https://stock-news.laohu8.com/highlight/detail?id=2606197307","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606197307?lang=en_us&edition=fundamental","pubTime":"2026-01-28 21:01","pubTimestamp":1769605306,"startTime":"0","endTime":"0","summary":"Natera Inc. has announced the completion of enrollment in the ACES-EMB clinical trial, the first randomized-controlled study comparing non-invasive donor-derived cell-free DNA  surveillance using the Prospera Heart test to routine endomyocardial biopsy  for monitoring heart transplant rejection. The trial enrolled over 300 patients at 17 U.S. transplant centers, with participants randomized one month after transplant to either Prospera-based surveillance or standard EMB-based care. Patients will be followed for 12 months. The results of the study have not yet been presented and are expected in the future.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Natera Inc. published the original content used to generate this news brief via Busin","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nNDL3N1f3H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345770993.USD","LU1064131342.USD","LU2324357040.USD","LU0053671581.USD","LU0106261612.USD","LU2065169927.USD","LU2264538146.SGD","BK4139","LU0012050646.USD","NTRA","LU2065171311.SGD","LU0345770308.USD","LU0963586101.USD","LU1988902786.USD","LU2065170008.USD","LU2065171402.SGD","LU2065731478.USD"],"gpt_icon":0},{"id":"2606719417","title":"Natera Announces Completion of Enrollment in Randomized Aces-Emb Trial in Heart Transplantation","url":"https://stock-news.laohu8.com/highlight/detail?id=2606719417","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606719417?lang=en_us&edition=fundamental","pubTime":"2026-01-28 21:00","pubTimestamp":1769605206,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nTUAB4RWKN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2264538146.SGD","LU0345770308.USD","LU1988902786.USD","LU2324357040.USD","LU1064131342.USD","LU2065170008.USD","BK4139","LU0963586101.USD","LU0012050646.USD","NTRA","LU2065171402.SGD","LU0053671581.USD","LU2065171311.SGD","LU0345770993.USD","LU2065731478.USD","LU0106261612.USD","LU2065169927.USD"],"gpt_icon":0},{"id":"2606475723","title":"Natera Inc. Co-Founder and Director Jonathan Sheena Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2606475723","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606475723?lang=en_us&edition=fundamental","pubTime":"2026-01-28 09:35","pubTimestamp":1769564139,"startTime":"0","endTime":"0","summary":"Jonathan Sheena, Co-Founder and Director of Natera Inc., reported a disposal of common shares of Natera Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Natera Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 27, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nNDL2bwSkN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Natera Inc. Co-Founder and Director Jonathan Sheena Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064131342.USD","LU2065171402.SGD","LU0345770308.USD","LU0345770993.USD","BK4139","LU2065169927.USD","LU0106261612.USD","NTRA","LU0012050646.USD","LU2065171311.SGD","LU0963586101.USD","LU2065170008.USD","LU2324357040.USD","LU0053671581.USD","LU2065731478.USD","LU2264538146.SGD","LU1988902786.USD"],"gpt_icon":0},{"id":"2606211244","title":"Natera Study Shows Prospera Test Reduces Need for Routine Lung Transplant Biopsies","url":"https://stock-news.laohu8.com/highlight/detail?id=2606211244","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606211244?lang=en_us&edition=fundamental","pubTime":"2026-01-26 19:01","pubTimestamp":1769425290,"startTime":"0","endTime":"0","summary":"Natera Inc. has announced the publication of a new prospective clinical trial in the journal Transplantation Direct, evaluating the use of its Prospera donor-derived cell-free DNA  test for lung transplant recipients. Conducted by The Ohio State University Wexner Medical Center, the study assessed whether Prospera-guided monitoring could reduce the need for routine transbronchial biopsies after lung transplantation. Results from the clinical trial have been published and indicate that physicians omitted the 9-month biopsy in approximately 75% of patients identified as low risk by Prospera, with no significant difference in acute rejection rates, lung function, or immunologic stability compared to patients who underwent the biopsy. At one year post-transplant, about 95% of patients who skipped the 9-month biopsy did not require treatment for acute rejection. The findings suggest that Prospera-guided care may help reduce invasive procedures while maintaining patient outcomes.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nNDL7J5NvQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064131342.USD","NTRA","LU2065171311.SGD","LU0106261612.USD","LU2264538146.SGD","LU0012050646.USD","LU0345770308.USD","LU2324357040.USD","LU0345770993.USD","LU0963586101.USD","BK4139","LU2065171402.SGD","LU0053671581.USD","LU2065170008.USD","LU2065169927.USD","LU2065731478.USD","LU1988902786.USD"],"gpt_icon":0},{"id":"2605466571","title":"Analysts’ Top Healthcare Picks: Natera (NTRA), Corcept Therapeutics (CORT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2605466571","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605466571?lang=en_us&edition=fundamental","pubTime":"2026-01-22 16:20","pubTimestamp":1769070012,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Natera (NTRA – Research Report), Corcept Therapeutic...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-natera-ntra-corcept-therapeutics-cort-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-natera-ntra-corcept-therapeutics-cort-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU0345770308.USD","LU1559883803.SGD","LU2065170008.USD","LU2065171402.SGD","LU2264538146.SGD","NTRA","LU0963586101.USD","BK4007","LU0345770993.USD","LU0106261612.USD","LU1064131342.USD","XBI","LU2324357040.USD","LU2065169927.USD","LU0053671581.USD","LU2065731478.USD","XLV","CORT","BK4581","LU2065171311.SGD","LU0012050646.USD","LU1988902786.USD","LABU","LU0566484027.USD","HCSG","BK4532","LU0128526141.USD","BK4585","LU0029874061.USD","BK4137","BK4588"],"gpt_icon":0},{"id":"2605106129","title":"Natera announces publication of validation study for Latitude tissue-free assay","url":"https://stock-news.laohu8.com/highlight/detail?id=2605106129","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605106129?lang=en_us&edition=fundamental","pubTime":"2026-01-21 19:11","pubTimestamp":1768993863,"startTime":"0","endTime":"0","summary":"Natera (NTRA) announced the publication in npj Precision Oncology of the validation study for its Latitude tissue-free molecular residual disease a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/natera-announces-publication-of-validation-study-for-latitude-tissue-free-assay-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/natera-announces-publication-of-validation-study-for-latitude-tissue-free-assay-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1988902786.USD","LU1064131342.USD","LU2065171402.SGD","LU0345770308.USD","LU2264538146.SGD","LU0963586101.USD","LU2065171311.SGD","LU2324357040.USD","LU2065169927.USD","NTRA","LU0012050646.USD","LU0106261612.USD","LU0345770993.USD","LU2065170008.USD","LU2065731478.USD","LU0053671581.USD","BK4139"],"gpt_icon":0},{"id":"2605105445","title":"Natera Launches Latitude Tissue-Free MRD Test With High Sensitivity in Colorectal Cancer Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2605105445","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605105445?lang=en_us&edition=fundamental","pubTime":"2026-01-21 19:00","pubTimestamp":1768993217,"startTime":"0","endTime":"0","summary":"Natera Inc. has announced the publication of a clinical validation study for its Latitude tissue-free molecular residual disease  assay in colorectal cancer  in npj Precision Oncology. The study builds upon data previously presented at the 2025 European Society for Medical Oncology GI Congress . Latitude is a methylation-based test that detects circulating tumor DNA  without requiring tumor tissue, complementing Natera's existing tumor-informed Signatera test. The validation study analyzed 1,230 timepoints from 195 CRC patients enrolled in the GALAXY clinical trial. Key findings include a longitudinal sensitivity of 84.4% and a median lead time of 4.6 months ahead of radiographic recurrence. The test demonstrated 97.2% sample-level specificity and 92.1% patient-level specificity. MRD-positivity was associated with worse outcomes in both MRD and surveillance settings, and MRD-positive patients in high-risk stage II and stage III groups experienced significant benefit from adjuvant chemo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nNDL1rh0hm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345770308.USD","LU0012050646.USD","LU0963586101.USD","BK4139","LU2065731478.USD","LU2264538146.SGD","LU2324357040.USD","NTRA","LU2065171402.SGD","LU1988902786.USD","LU0106261612.USD","LU0345770993.USD","LU2065169927.USD","LU2065171311.SGD","LU1064131342.USD","LU0053671581.USD","LU2065170008.USD"],"gpt_icon":0},{"id":"2604194109","title":"Natera Showcases Fetal Focus Single Gene NIPT Clinical Trial Results at SMFM Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2604194109","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604194109?lang=en_us&edition=fundamental","pubTime":"2026-01-20 19:00","pubTimestamp":1768906847,"startTime":"0","endTime":"0","summary":"Natera Inc. has announced that data from its EXPAND clinical trial, which evaluates the Fetal Focus Single Gene Non-Invasive Prenatal Test , will be presented in an oral plenary session at the Society of Maternal Fetal Medicine  meeting scheduled for February 8-13, 2026. The EXPAND study is a prospective, blinded trial designed to validate the use of Fetal Focus in identifying inherited conditions by analyzing 21 genes associated with serious, early-onset medical conditions. According to Natera, the oral presentation will detail the study's key results and methodology, including confirmation of all outcomes against genetic truth standards. Additional Natera presentations at SMFM will highlight data from the VANISH clinical trial, which focuses on the interpretation of cell-free DNA patterns in vanishing twin pregnancies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nNDL4CGPjV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171311.SGD","LU0106261612.USD","LU0963586101.USD","LU1064131342.USD","LU1988902786.USD","BK4139","LU2065731478.USD","LU2264538146.SGD","LU2065170008.USD","LU0012050646.USD","LU0345770993.USD","LU2065171402.SGD","LU2324357040.USD","LU2065169927.USD","NTRA","LU0345770308.USD","LU0053671581.USD"],"gpt_icon":0},{"id":"2603648063","title":"Natera Targets Endometrial Cancer With New Signatera Trial, Expanding Its MRD Opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=2603648063","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603648063?lang=en_us&edition=fundamental","pubTime":"2026-01-15 00:32","pubTimestamp":1768408334,"startTime":"0","endTime":"0","summary":"Natera Inc. ($NTRA) announced an update on their ongoing clinical study. Natera’s new trial, “Circulating Tumor DNA Assessment in Early-Stage Endom...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/natera-targets-endometrial-cancer-with-new-signatera-trial-expanding-its-mrd-opportunity?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/natera-targets-endometrial-cancer-with-new-signatera-trial-expanding-its-mrd-opportunity?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0963586101.USD","LU0053671581.USD","LU2065171402.SGD","NTRA","LU2065731478.USD","LU0106261612.USD","LU2065170008.USD","LU2065171311.SGD","LU0012050646.USD","BK4139","LU1064131342.USD","LU1988902786.USD","LU0345770308.USD","LU0345770993.USD","LU2324357040.USD","LU2264538146.SGD","LU2065169927.USD"],"gpt_icon":0},{"id":"2603656906","title":"Natera Inc. unveils investor presentation highlighting advances in cell-free DNA technology and record growth across core products","url":"https://stock-news.laohu8.com/highlight/detail?id=2603656906","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603656906?lang=en_us&edition=fundamental","pubTime":"2026-01-14 07:20","pubTimestamp":1768346435,"startTime":"0","endTime":"0","summary":"Natera Inc. unveils investor presentation highlighting advances in cell-free DNA technology and record growth across core products. Natera Inc. presented at the 44th Annual J.P. Morgan Healthcare Conference, highlighting significant growth in its core business areas. The company reported record test volumes in the fourth quarter, driven by continued momentum across its product portfolio, including notable sequential growth for its Signatera test and strong interest in the Fetal Focus offering. Natera also announced the launch of its 21-gene Fetal Focus single-gene noninvasive prenatal test , featuring ultrasensitive technology and flexible ordering options. Financially, the company reported approximately 39% year-over-year revenue growth for the fourth quarter of 2025 and generated more than $100 million in free cash flow during the year. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artifici","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nNDL1ldGB5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065170008.USD","LU2264538146.SGD","LU2324357040.USD","LU2065731478.USD","LU1064131342.USD","LU2065171311.SGD","LU0106261612.USD","LU0963586101.USD","LU2065171402.SGD","NTRA","LU0345770308.USD","LU0053671581.USD","BK4139","LU1988902786.USD","LU0345770993.USD","LU2065169927.USD","LU0012050646.USD"],"gpt_icon":0},{"id":"2603636734","title":"Natera’s SCORE Study Builds Real-World Evidence for Cancer MRD Testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2603636734","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603636734?lang=en_us&edition=fundamental","pubTime":"2026-01-14 00:31","pubTimestamp":1768321879,"startTime":"0","endTime":"0","summary":"Natera Inc. ($NTRA) announced an update on their ongoing clinical study. The SCORE (Sample Collection for Ongoing Research and Product Evaluation) ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nateras-score-study-builds-real-world-evidence-for-cancer-mrd-testing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nateras-score-study-builds-real-world-evidence-for-cancer-mrd-testing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0345770308.USD","LU2065171402.SGD","NTRA","LU2065170008.USD","BK4139","LU0345770993.USD","LU2065171311.SGD","LU2065169927.USD","LU2324357040.USD","LU0106261612.USD","LU1988902786.USD","LU2264538146.SGD","LU0963586101.USD","LU0053671581.USD","LU1064131342.USD","LU2065731478.USD","LU0012050646.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":1,"totalSize":170,"code":"91000000","status":"200"}]}}